Cleveland Clinic, Mount Sinai Wont Give Biogens New Alzheimers Drug – The Wall Street Journal

A pair of large hospitals are declining to administer
Biogen Inc.s
BIIB -7.44%
new Alzheimers treatment, Aduhelm, the latest rupture to emerge from the Food and Drug Administrations controversial… [+3861 chars]